Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal Cancer.

Salem ME, Battaglin F, Goldberg RM, Puccini A, Shields AF, Arguello D, Korn WM, Marshall JL, Grothey A, Lenz HJ.

Oncologist. 2019 Dec 17. pii: theoncologist.2019-0552. doi: 10.1634/theoncologist.2019-0552. [Epub ahead of print]

2.

Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor.

Chen H, Liu S, Padula S, Lesman D, Griswold K, Lin A, Zhao T, Marshall JL, Chen F.

Nat Biotechnol. 2019 Dec 16. doi: 10.1038/s41587-019-0331-8. [Epub ahead of print]

PMID:
31844291
3.

Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation.

Subramanian A, Sidhom EH, Emani M, Vernon K, Sahakian N, Zhou Y, Kost-Alimova M, Slyper M, Waldman J, Dionne D, Nguyen LT, Weins A, Marshall JL, Rosenblatt-Rosen O, Regev A, Greka A.

Nat Commun. 2019 Nov 29;10(1):5462. doi: 10.1038/s41467-019-13382-0.

4.

Detection of CMB-Cluster Lensing using Polarization Data from SPTpol.

Raghunathan S, Patil S, Baxter E, Benson BA, Bleem LE, Crawford TM, Holder GP, McClintock T, Reichardt CL, Varga TN, Whitehorn N, Ade PAR, Allam S, Anderson AJ, Austermann JE, Avila S, Avva JS, Bacon D, Beall JA, Bender AN, Bianchini F, Bocquet S, Brooks D, Burke DL, Carlstrom JE, Carretero J, Castander FJ, Chang CL, Chiang HC, Citron R, Costanzi M, Crites AT, da Costa LN, Desai S, Diehl HT, Dietrich JP, Dobbs MA, Doel P, Everett S, Evrard AE, Feng C, Flaugher B, Fosalba P, Frieman J, Gallicchio J, García-Bellido J, Gaztanaga E, George EM, Giannantonio T, Gilbert A, Gruendl RA, Gschwend J, Gupta N, Gutierrez G, de Haan T, Halverson NW, Harrington N, Henning JW, Hilton GC, Hollowood DL, Holzapfel WL, Honscheid K, Hrubes JD, Huang N, Hubmayr J, Irwin KD, Jeltema T, Kind MC, Knox L, Kuropatkin N, Lahav O, Lee AT, Li D, Lima M, Lowitz A, Maia MAG, Marshall JL, McMahon JJ, Melchior P, Menanteau F, Meyer SS, Miquel R, Mocanu LM, Mohr JJ, Montgomery J, Moran CC, Nadolski A, Natoli T, Nibarger JP, Noble G, Novosad V, Ogando RLC, Padin S, Plazas AA, Pryke C, Rapetti D, Romer AK, Roodman A, Rosell AC, Rozo E, Ruhl JE, Rykoff ES, Saliwanchik BR, Sanchez E, Sayre JT, Scarpine V, Schaffer KK, Schubnell M, Serrano S, Sevilla-Noarbe I, Sievers C, Smecher G, Smith M, Soares-Santos M, Stark AA, Story KT, Suchyta E, Swanson MEC, Tarle G, Tucker C, Vanderlinde K, Veach T, De Vicente J, Vieira JD, Vikram V, Wang G, Wu WLK, Yefremenko V, Zhang Y; SPTpol and DES Collaboration.

Phys Rev Lett. 2019 Nov 1;123(18):181301. doi: 10.1103/PhysRevLett.123.181301.

PMID:
31763885
5.

Sequencing beyond the second-line setting in metastatic colorectal cancer: further observations.

Grothey A, Marshall JL, Bekaii-Saab T.

Clin Adv Hematol Oncol. 2019 Mar;17 Suppl 7(3):16-18. No abstract available.

PMID:
31730592
6.

Options for patients with metastatic colorectal cancer who progress after second-line therapy.

Marshall JL.

Clin Adv Hematol Oncol. 2019 Mar;17 Suppl 7(3):2-4. No abstract available.

PMID:
31730589
7.

Sequencing beyond the second-line setting in metastatic colorectal cancer.

Grothey A, Marshall JL, Bekaii-Saab T.

Clin Adv Hematol Oncol. 2019 Mar;17 Suppl 7(3):1-19.

PMID:
31730588
8.

Counselling interventions to enable women to initiate and continue breastfeeding: a systematic review and meta-analysis.

McFadden A, Siebelt L, Marshall JL, Gavine A, Girard LC, Symon A, MacGillivray S.

Int Breastfeed J. 2019 Oct 21;14:42. doi: 10.1186/s13006-019-0235-8. eCollection 2019. Review.

9.

Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment.

Hsu C, Marshall JL, He AR.

Oncologist. 2019 Sep 9. pii: theoncologist.2018-0162. doi: 10.1634/theoncologist.2018-0162. [Epub ahead of print]

10.

Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.

Hu Y, Mohassel P, Donkervoort S, Yun P, Bolduc V, Ezzo D, Dastgir J, Marshall JL, Lek M, MacArthur DG, Foley AR, Bönnemann CG.

J Neuromuscul Dis. 2019;6(4):475-483. doi: 10.3233/JND-190414.

PMID:
31498126
11.

Workup and Management of Immune-Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors.

Singh BP, Marshall JL, He AR.

Oncologist. 2019 Sep 6. pii: theoncologist.2018-0304. doi: 10.1634/theoncologist.2018-0304. [Epub ahead of print]

12.

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets.

Weinberg BA, Xiu J, Lindberg MR, Shields AF, Hwang JJ, Poorman K, Salem ME, Pishvaian MJ, Holcombe RF, Marshall JL, Morse MA.

J Gastrointest Oncol. 2019 Aug;10(4):652-662. doi: 10.21037/jgo.2018.08.18.

13.

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich S, Kim E, Brenner AJ, Marshall JL.

CA Cancer J Clin. 2019 Jul;69(4):305-343. doi: 10.3322/caac.21560. Epub 2019 May 22. Review.

14.

Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Abbott TMC, Alarcon A, Allam S, Andersen P, Andrade-Oliveira F, Annis J, Asorey J, Avila S, Bacon D, Banik N, Bassett BA, Baxter E, Bechtol K, Becker MR, Bernstein GM, Bertin E, Blazek J, Bridle SL, Brooks D, Brout D, Burke DL, Calcino J, Camacho H, Campos A, Carnero Rosell A, Carollo D, Carrasco Kind M, Carretero J, Castander FJ, Cawthon R, Challis P, Chan KC, Chang C, Childress M, Crocce M, Cunha CE, D'Andrea CB, da Costa LN, Davis C, Davis TM, De Vicente J, DePoy DL, DeRose J, Desai S, Diehl HT, Dietrich JP, Dodelson S, Doel P, Drlica-Wagner A, Eifler TF, Elvin-Poole J, Estrada J, Evrard AE, Fernandez E, Flaugher B, Foley RJ, Fosalba P, Frieman J, Galbany L, García-Bellido J, Gatti M, Gaztanaga E, Gerdes DW, Giannantonio T, Glazebrook K, Goldstein DA, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hartley WG, Hinton SR, Hollowood DL, Honscheid K, Hoormann JK, Hoyle B, Huterer D, Jain B, James DJ, Jarvis M, Jeltema T, Kasai E, Kent S, Kessler R, Kim AG, Kokron N, Krause E, Kron R, Kuehn K, Kuropatkin N, Lahav O, Lasker J, Lemos P, Lewis GF, Li TS, Lidman C, Lima M, Lin H, Macaulay E, MacCrann N, Maia MAG, March M, Marriner J, Marshall JL, Martini P, McMahon RG, Melchior P, Menanteau F, Miquel R, Mohr JJ, Morganson E, Muir J, Möller A, Neilsen E, Nichol RC, Nord B, Ogando RLC, Palmese A, Pan YC, Peiris HV, Percival WJ, Plazas AA, Porredon A, Prat J, Romer AK, Roodman A, Rosenfeld R, Ross AJ, Rykoff ES, Samuroff S, Sánchez C, Sanchez E, Scarpine V, Schindler R, Schubnell M, Scolnic D, Secco LF, Serrano S, Sevilla-Noarbe I, Sharp R, Sheldon E, Smith M, Soares-Santos M, Sobreira F, Sommer NE, Swann E, Swanson MEC, Tarle G, Thomas D, Thomas RC, Troxel MA, Tucker BE, Uddin SA, Vielzeuf P, Walker AR, Wang M, Weaverdyck N, Wechsler RH, Weller J, Yanny B, Zhang B, Zhang Y, Zuntz J; DES Collaboration.

Phys Rev Lett. 2019 May 3;122(17):171301. doi: 10.1103/PhysRevLett.122.171301.

15.

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Tesfaye AA, Wang H, Hartley ML, He AR, Weiner L, Gabelia N, Kapanadze L, Shezad M, Brody JR, Marshall JL, Pishvaian MJ.

J Pancreat Cancer. 2019 May 2;5(1):12-21. doi: 10.1089/pancan.2019.0003. eCollection 2019.

16.

Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation.

Sun D, Stopka-Farooqui U, Barry S, Aksoy E, Parsonage G, Vossenkämper A, Capasso M, Wan X, Norris S, Marshall JL, Clear A, Gribben J, MacDonald TT, Buckley CD, Korbonits M, Haworth O.

Cell Rep. 2019 Apr 30;27(5):1461-1471.e4. doi: 10.1016/j.celrep.2019.04.014.

17.

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.

Manjaly Thomas ZR, Satti I, Marshall JL, Harris SA, Lopez Ramon R, Hamidi A, Minhinnick A, Riste M, Stockdale L, Lawrie AM, Vermaak S, Wilkie M, Bettinson H, McShane H.

PLoS Med. 2019 Apr 30;16(4):e1002790. doi: 10.1371/journal.pmed.1002790. eCollection 2019 Apr.

18.

Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.

Parvatiyar MS, Brownstein AJ, Kanashiro-Takeuchi RM, Collado JR, Dieseldorff Jones KM, Gopal J, Hammond KG, Marshall JL, Ferrel A, Beedle AM, Chamberlain JS, Renato Pinto J, Crosbie RH.

JCI Insight. 2019 Apr 30;5. pii: 123855. doi: 10.1172/jci.insight.123855.

19.

A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies.

Bolduc V, Foley AR, Solomon-Degefa H, Sarathy A, Donkervoort S, Hu Y, Chen GS, Sizov K, Nalls M, Zhou H, Aguti S, Cummings BB, Lek M, Tukiainen T, Marshall JL, Regev O, Marek-Yagel D, Sarkozy A, Butterfield RJ, Jou C, Jimenez-Mallebrera C, Li Y, Gartioux C, Mamchaoui K, Allamand V, Gualandi F, Ferlini A, Hanssen E; COL6A1 Intron 11 Study Group, Wilton SD, Lamandé SR, MacArthur DG, Wagener R, Muntoni F, Bönnemann CG.

JCI Insight. 2019 Mar 21;4(6). pii: 124403. doi: 10.1172/jci.insight.124403. eCollection 2019 Mar 21.

20.

Biomarkers for immune therapy in gastrointestinal cancers.

Weinberg BA, Hameed R, Marshall JL.

Clin Adv Hematol Oncol. 2019 Feb;17(2):109-119. Review.

PMID:
30845114
21.

Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets.

Ward LSC, Sheriff L, Marshall JL, Manning JE, Brill A, Nash GB, McGettrick HM.

J Cell Sci. 2019 Feb 25;132(5). pii: jcs222067. doi: 10.1242/jcs.222067.

22.

Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.

Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Naseem M, Lo JH, Arai H, Battaglin F, Puccini A, Berger MD, Soni S, Zhang W, Hwang JJ, Shields AF, Marshall JL, Baba H, Korn WM, Lenz HJ.

Clin Cancer Res. 2019 May 15;25(10):3096-3103. doi: 10.1158/1078-0432.CCR-18-3388. Epub 2019 Jan 28.

PMID:
30692096
23.

Colon Cancer in Young Adults: Trends and Their Implications.

Weinberg BA, Marshall JL.

Curr Oncol Rep. 2019 Jan 18;21(1):3. doi: 10.1007/s11912-019-0756-8. Review.

PMID:
30659375
24.

Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?

Aungier SR, Cartwright AJ, Schwenzer A, Marshall JL, Dyson MR, Slavny P, Parthiban K, Karatt-Vellatt A, Sahbudin I, Culbert E, Hextall P, Clanchy FI, Williams R, Marsden BD, Raza K, Filer A, Buckley CD, McCafferty J, Midwood KS.

Ann Rheum Dis. 2019 Feb;78(2):186-191. doi: 10.1136/annrheumdis-2018-214294. Epub 2018 Dec 14.

25.

Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.

Vietsch EE, Graham GT, McCutcheon JN, Javaid A, Giaccone G, Marshall JL, Wellstein A.

Cancer Genet. 2018 Dec;228-229:131-142. doi: 10.1016/j.cancergen.2018.11.001. Epub 2018 Nov 9.

PMID:
30447903
26.

Intestinal CD103+CD11b+ cDC2 Conventional Dendritic Cells Are Required for Primary CD4+ T and B Cell Responses to Soluble Flagellin.

Flores-Langarica A, Cook C, Müller Luda K, Persson EK, Marshall JL, Beristain-Covarrubias N, Yam-Puc JC, Dahlgren M, Persson JJ, Uematsu S, Akira S, Henderson IR, Lindbom BJ, Agace W, Cunningham AF.

Front Immunol. 2018 Oct 17;9:2409. doi: 10.3389/fimmu.2018.02409. eCollection 2018.

27.

Underuse of exon mutational analysis for gastrointestinal stromal tumors.

Bartholomew AJ, Dohnalek H, Prins PA, O'Neill SC, Quadri HS, Marshall JL, Haddad NG, Al-Refaie WB.

J Surg Res. 2018 Nov;231:43-48. doi: 10.1016/j.jss.2018.05.014. Epub 2018 Jun 7.

PMID:
30278964
28.

Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.

Salem ME, Yin J, Weinberg BA, Renfro LA, Pederson LD, Maughan TS, Adams RA, Van Cutsem E, Falcone A, Tebbutt NC, Seymour MT, Díaz-Rubio E, Aranda E, Bokemeyer C, Heinemann V, Wasan H, de Gramont A, Grothey A, Shi Q, Sargent DJ, Marshall JL.

Eur J Cancer. 2018 Nov;103:205-213. doi: 10.1016/j.ejca.2018.08.020. Epub 2018 Sep 27.

29.

Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types.

Heeke AL, Pishvaian MJ, Lynce F, Xiu J, Brody JR, Chen WJ, Baker TM, Marshall JL, Isaacs C.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00286. Epub 2018 Jul 23.

30.

Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States.

Kim S, Signorovitch JE, Yang H, Patterson-Lomba O, Xiang CQ, Ung B, Parisi M, Marshall JL.

Adv Ther. 2018 Oct;35(10):1564-1577. doi: 10.1007/s12325-018-0784-z. Epub 2018 Sep 12.

31.

Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal Tumors.

Puccini A, Lenz HJ, Marshall JL, Arguello D, Raghavan D, Korn WM, Weinberg BA, Poorman K, Heeke AL, Philip PA, Shields AF, Goldberg RM, Salem ME.

Oncologist. 2019 Mar;24(3):319-326. doi: 10.1634/theoncologist.2018-0117. Epub 2018 Jul 17.

32.

Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.

Salem ME, Puccini A, Xiu J, Raghavan D, Lenz HJ, Korn WM, Shields AF, Philip PA, Marshall JL, Goldberg RM.

Oncologist. 2018 Nov;23(11):1319-1327. doi: 10.1634/theoncologist.2018-0143. Epub 2018 Jun 4.

33.

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease.

Boyiadzis MM, Kirkwood JM, Marshall JL, Pritchard CC, Azad NS, Gulley JL.

J Immunother Cancer. 2018 May 14;6(1):35. doi: 10.1186/s40425-018-0342-x. Review.

34.

Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.

Weinberg BA, Xiu J, Hwang JJ, Shields AF, Salem ME, Marshall JL.

Oncologist. 2018 Oct;23(10):1171-1177. doi: 10.1634/theoncologist.2018-0034. Epub 2018 Apr 27.

35.

Congenital Titinopathy: Comprehensive characterization and pathogenic insights.

Oates EC, Jones KJ, Donkervoort S, Charlton A, Brammah S, Smith JE 3rd, Ware JS, Yau KS, Swanson LC, Whiffin N, Peduto AJ, Bournazos A, Waddell LB, Farrar MA, Sampaio HA, Teoh HL, Lamont PJ, Mowat D, Fitzsimons RB, Corbett AJ, Ryan MM, O'Grady GL, Sandaradura SA, Ghaoui R, Joshi H, Marshall JL, Nolan MA, Kaur S, Punetha J, Töpf A, Harris E, Bakshi M, Genetti CA, Marttila M, Werlauff U, Streichenberger N, Pestronk A, Mazanti I, Pinner JR, Vuillerot C, Grosmann C, Camacho A, Mohassel P, Leach ME, Foley AR, Bharucha-Goebel D, Collins J, Connolly AM, Gilbreath HR, Iannaccone ST, Castro D, Cummings BB, Webster RI, Lazaro L, Vissing J, Coppens S, Deconinck N, Luk HM, Thomas NH, Foulds NC, Illingworth MA, Ellard S, McLean CA, Phadke R, Ravenscroft G, Witting N, Hackman P, Richard I, Cooper ST, Kamsteeg EJ, Hoffman EP, Bushby K, Straub V, Udd B, Ferreiro A, North KN, Clarke NF, Lek M, Beggs AH, Bönnemann CG, MacArthur DG, Granzier H, Davis MR, Laing NG.

Ann Neurol. 2018 Jun;83(6):1105-1124. doi: 10.1002/ana.25241.

36.

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.

Pishvaian MJ, Slack RS, Jiang W, He AR, Hwang JJ, Hankin A, Dorsch-Vogel K, Kukadiya D, Weiner LM, Marshall JL, Brody JR.

Cancer. 2018 Jun 1;124(11):2337-2346. doi: 10.1002/cncr.31309. Epub 2018 Mar 26.

37.

Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.

Domenyuk V, Gatalica Z, Santhanam R, Wei X, Stark A, Kennedy P, Toussaint B, Levenberg S, Wang J, Xiao N, Greil R, Rinnerthaler G, Gampenrieder SP, Heimberger AB, Berry DA, Barker A, Quackenbush J, Marshall JL, Poste G, Vacirca JL, Vidal GA, Schwartzberg LS, Halbert DD, Voss A, Magee D, Miglarese MR, Famulok M, Mayer G, Spetzler D.

Nat Commun. 2018 Mar 23;9(1):1219. doi: 10.1038/s41467-018-03631-z.

38.

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers.

Salem ME, Puccini A, Grothey A, Raghavan D, Goldberg RM, Xiu J, Korn WM, Weinberg BA, Hwang JJ, Shields AF, Marshall JL, Philip PA, Lenz HJ.

Mol Cancer Res. 2018 May;16(5):805-812. doi: 10.1158/1541-7786.MCR-17-0735. Epub 2018 Mar 9.

39.

Corrigendum: Landscape of X chromosome inactivation across human tissues.

Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, Consortium G, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG.

Nature. 2018 Mar 7;555(7695):274. doi: 10.1038/nature25993.

PMID:
29517003
40.

Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis.

Mizoguchi F, Slowikowski K, Wei K, Marshall JL, Rao DA, Chang SK, Nguyen HN, Noss EH, Turner JD, Earp BE, Blazar PE, Wright J, Simmons BP, Donlin LT, Kalliolias GD, Goodman SM, Bykerk VP, Ivashkiv LB, Lederer JA, Hacohen N, Nigrovic PA, Filer A, Buckley CD, Raychaudhuri S, Brenner MB.

Nat Commun. 2018 Feb 23;9(1):789. doi: 10.1038/s41467-018-02892-y.

41.

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies.

Deeken JF, Wang H, Hartley M, Cheema AK, Smaglo B, Hwang JJ, He AR, Weiner LM, Marshall JL, Giaccone G, Liu S, Luecht J, Spiegel JY, Pishvaian MJ.

Cancer Chemother Pharmacol. 2018 Mar;81(3):587-596. doi: 10.1007/s00280-018-3533-8. Epub 2018 Feb 1.

PMID:
29392450
42.

CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin.

Flores-Langarica A, Müller Luda K, Persson EK, Cook CN, Bobat S, Marshall JL, Dahlgren MW, Hägerbrand K, Toellner KM, Goodall MD, Withers DR, Henderson IR, Johansson Lindbom B, Cunningham AF, Agace WW.

Mucosal Immunol. 2018 May;11(3):681-692. doi: 10.1038/mi.2017.105. Epub 2017 Dec 20.

43.

Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?

Trivedi ND, Marshall JL.

Oncology (Williston Park). 2017 Dec 15;31(12):863-5, 871, 884. No abstract available.

44.

Molecular characteristics of hepatocellular carcinomas from different age groups.

Ang C, Shields A, Xiu J, Gatalica Z, Reddy S, Salem ME, Farhangfar C, Hwang J, Astsaturov I, Marshall JL.

Oncotarget. 2017 Sep 27;8(60):101591-101598. doi: 10.18632/oncotarget.21353. eCollection 2017 Nov 24.

45.

"It's like rotations, but in the classroom": Creation of an innovative course to prepare students for advanced pharmacy practice experiences.

Hardy YM, Marshall JL.

Curr Pharm Teach Learn. 2017 Nov;9(6):1129-1140. doi: 10.1016/j.cptl.2017.07.009. Epub 2017 Aug 23.

PMID:
29233382
46.

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.

Salem ME, Weinberg BA, Xiu J, El-Deiry WS, Hwang JJ, Gatalica Z, Philip PA, Shields AF, Lenz HJ, Marshall JL.

Oncotarget. 2017 Sep 21;8(49):86356-86368. doi: 10.18632/oncotarget.21169. eCollection 2017 Oct 17.

47.

Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.

Vietsch EE, Graham GT, McCutcheon JN, Javaid A, Giaccone G, Marshall JL, Wellstein A.

Cancer Genet. 2017 Dec;218-219:39-50. doi: 10.1016/j.cancergen.2017.08.006. Epub 2017 Sep 14.

48.

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal Cancer.

Grothey A, Strosberg JR, Renfro LA, Hurwitz HI, Marshall JL, Safran H, Guarino MJ, Kim GP, Hecht JR, Weil SC, Heyburn J, Wang W, Schweizer C, O'Shannessy DJ, Diaz LA Jr.

Clin Cancer Res. 2018 Jan 15;24(2):316-325. doi: 10.1158/1078-0432.CCR-17-1558. Epub 2017 Oct 30.

49.

Light curves of the neutron star merger GW170817/SSS17a: Implications for r-process nucleosynthesis.

Drout MR, Piro AL, Shappee BJ, Kilpatrick CD, Simon JD, Contreras C, Coulter DA, Foley RJ, Siebert MR, Morrell N, Boutsia K, Di Mille F, Holoien TW, Kasen D, Kollmeier JA, Madore BF, Monson AJ, Murguia-Berthier A, Pan YC, Prochaska JX, Ramirez-Ruiz E, Rest A, Adams C, Alatalo K, Bañados E, Baughman J, Beers TC, Bernstein RA, Bitsakis T, Campillay A, Hansen TT, Higgs CR, Ji AP, Maravelias G, Marshall JL, Bidin CM, Prieto JL, Rasmussen KC, Rojas-Bravo C, Strom AL, Ulloa N, Vargas-González J, Wan Z, Whitten DD.

Science. 2017 Dec 22;358(6370):1570-1574. doi: 10.1126/science.aaq0049. Epub 2017 Oct 16.

PMID:
29038375
50.

Early spectra of the gravitational wave source GW170817: Evolution of a neutron star merger.

Shappee BJ, Simon JD, Drout MR, Piro AL, Morrell N, Prieto JL, Kasen D, Holoien TW, Kollmeier JA, Kelson DD, Coulter DA, Foley RJ, Kilpatrick CD, Siebert MR, Madore BF, Murguia-Berthier A, Pan YC, Prochaska JX, Ramirez-Ruiz E, Rest A, Adams C, Alatalo K, Bañados E, Baughman J, Bernstein RA, Bitsakis T, Boutsia K, Bravo JR, Di Mille F, Higgs CR, Ji AP, Maravelias G, Marshall JL, Placco VM, Prieto G, Wan Z.

Science. 2017 Dec 22;358(6370):1574-1578. doi: 10.1126/science.aaq0186. Epub 2017 Oct 16.

PMID:
29038374

Supplemental Content

Loading ...
Support Center